| --- | --- | --- | --- | --- | |----------------------------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | ImmuCell Corporation Investor Presentation February 2021 | | | | | | | | | | | Forward-Looking Statements Cautionary Note Regarding Forward-Looking Statements (Safe Harbor Statement): Such statements include, but are not limited to, any statements relating to: our plans and strategies for our business; projections of future financial or operational performanc ...

ImmuCell Corporation (NASDAQ:ICCC) Q3 2020 Earnings Conference Call November 13, 2020 9:00 AM ET Company Participants Joe Diaz - Lytham Partners Michael Brigham - President and CEO Conference Call Participants Sam Rebotsky - SER Asset Management Operator Good morning and welcome to the ImmuCell Corporation reports Third Quarter Fiscal Year 2020 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity t ...

| --- | --- | --- | --- | --- | |------------------------------------------------------------|-------|-------|-------|-------| | | | | | | | ImmuCell Corporation Investor Presentation November 2020 | | | | | | | | | | | Forward-Looking Statements Cautionary Note Regarding Forward-Looking Statements (Safe Harbor Statement): Such statements include, but are not limited to, any statements relating to: our plans and strategies for our business; projections of future financial or operational performance; the tim ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 001-12934 (Commission file number) ImmuCell Corporation (Exact name of registrant as specified in its charter) | Delaware | 01-0382980 | | --- | --- | | (State of Incorporation) | (I.R.S. Employer Identification No.) | | 56 Evergreen Drive, Portland, ME | 04103 | | (Address of principal ex ...

| --- | --- | --- | --- | --- | |----------------------------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | ImmuCell Corporation Investor Presentation August 2020 | | | | | | | | | | | Forward-Looking Statements Cautionary Note Regarding Forward-Looking Statements (Safe Harbor Statement): This Presentation contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Suc ...

ImmuCell Corporation (NASDAQ:ICCC) Q2 2020 Results Earnings Conference Call August 13, 2020 9:00 AM ET Company Participants Michael Brigham - President, Chief Executive Officer, Director Joe Diaz - Investor Relations, Managing Partner at Lytham Partners Conference Call Participants Nathan Weinstein - Aegis Capital Sam Rebotsky - SER Asset Management Tom Fox - Private Investor Brad McCurtain - Maine Securities Operator Good morning everyone and welcome to the ImmuCell Corporation reports second quarter fisca ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 001-12934 (Commission file number) ImmuCell Corporation (Exact name of registrant as specified in its charter) | Delaware | 01-0382980 | | --- | --- | | (State of Incorporation) | (I.R.S. Employer | | | Identification No.) | | 56 Evergreen Drive, Portland, ME | 04103 | | (Address of principal e ...

ImmuCell Corporation (NASDAQ:ICCC) Q1 2020 Earnings Conference Call May 14, 2020 9:00 AM ET Company Participants Joe Diaz - Lytham Partners Michael Brigham - President and CEO Conference Call Participants Sam Rebotsky - SCR Asset Management Paul Nouri - Noble Equity Brad McCurtain - Maine Securities Operator Good morning and welcome to the ImmuCell Corporation Reports First Quarter Fiscal Year 2020 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded. I would ...

| --- | --- | --- | --- | --- | |-------------------------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | ImmuCell Corporation Investor Presentation May 2020 | | | | | | | | | | | Forward-Looking Statements Cautionary Note Regarding Forward-Looking Statements (Safe Harbor Statement): This Presentation contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such stat ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 001-12934 (Commission file number) ImmuCell Corporation (Exact name of registrant as specified in its charter) | Delaware | 01-0382980 | | --- | --- | | (State of Incorporation) | (I.R.S. Employer | | | Identification No.) | | 56 Evergreen Drive, Portland, ME | 04103 | | (Address of principal ...